You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API tretinoin and benzoyl peroxide


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing tretinoin and benzoyl peroxide

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Sol-Gel Technologies Inc TWYNEO tretinoin and benzoyl peroxide 79167-301 ANHYDROUS CITRIC ACID 2030-12-30
Sol-Gel Technologies Inc TWYNEO tretinoin and benzoyl peroxide 79167-301 BUTYLATED HYDROXYTOLUENE 2030-12-30
Sol-Gel Technologies Inc TWYNEO tretinoin and benzoyl peroxide 79167-301 CARBOMER HOMOPOLYMER TYPE C 2030-12-30
Sol-Gel Technologies Inc TWYNEO tretinoin and benzoyl peroxide 79167-301 CETRIMONIUM CHLORIDE 2030-12-30
Sol-Gel Technologies Inc TWYNEO tretinoin and benzoyl peroxide 79167-301 CETYL ALCOHOL 2030-12-30
Sol-Gel Technologies Inc TWYNEO tretinoin and benzoyl peroxide 79167-301 CYCLOMETHICONE 2030-12-30
Sol-Gel Technologies Inc TWYNEO tretinoin and benzoyl peroxide 79167-301 EDETATE DISODIUM 2030-12-30
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Subscribe

Detailed excipient profiles for tretinoin and benzoyl peroxide

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: BUTYLATED HYDROXYTOLUENE

Excipient focus: CARBOMER HOMOPOLYMER TYPE C

Excipient focus: CETRIMONIUM CHLORIDE

Excipient focus: CETYL ALCOHOL

Excipient focus: CYCLOMETHICONE

Excipient focus: EDETATE DISODIUM

Excipient focus: GLYCERIN

Excipient focus: GLYCERYL MONO AND DIPALMITOSTEARATE

Excipient focus: HYDROCHLORIC ACID

Excipient focus: IMIDUREA

Excipient focus: LACTIC ACID, L-

Excipient focus: PEG-100 STEARATE

Excipient focus: POLYQUATERNIUM-7

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SQUALANE

Excipient focus: TETRAETHYL SILICATE

Excipient focus: WATER

Excipient focus: WHITE WAX

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group